Now there are a whole new set of potential catalysts plus the "fact" that a noted bio-tech analyst states that a current share price of about .20 is realistic without attributing any value to Amarantus Diagnostics.
It's obvious to me that this is overdue for substantial positive news that will double the share price overnight.
I'm hoping to add another million shares before that happens.
Blackhawk,from your posts it appears your a black or white kinda guy.I t would be interesting to hear your prediction on AMBS pps for the short term and long term.
Market Data 
Markets 
AI
